Congratulations To The New 2012 -AAAS Fellows

Professors Jeffrey Schorey, Crislyn D'Souza-Schorey, Jeffrey Feder, and Olaf Wiest have been named Fellows of the American Association for the Advancement of Science in 2012. The CRND expresses its warmest congratulations to these distinguished investigators on their achievements and recognition.

Dr. Jeffrey Schorey has been cited for “notable contributions to the field of mycobacterial pathogenesis, particularly to our understanding of the dynamic interaction between mycobacteria and its host cell, the macrophage.” The goal of Dr. Schorey's investigation of the immunology and cell biology related to mycobacteria in host-cell interactions is to advance our ability to control mycobacterial infections such as M. tuberculosis (TB), M. avium (an infection seen in later stage AIDs and the elderly), and M. leprae. (Hansens's disease).

Dr. Crislyn D'Souza-Schorey has been cited for “distinguished contributions to the field of cancer cell biology, particularly for studies on membrane traffic and ARF proteins in cell motility and tumor invasion.” The goal of Dr. D'Souza-Schorey's work is to discover information on the pathogenesis of cancer, which will ultimately serve in the development of novel diagnostic and therapeutic strategies for cancer treatment.


Dr. Jeffrey Feder has been cited for “distinguished contributions to evolutionary biology in advancing our understanding of ecological adaptation and speciation, and in particular to speciation occurring with gene flow.” Dr. Feder's research in ecological genetics and evolution traces the processes involved in the division of evolutionarily distinct gene pools as species adapt environmentally and give rise to new species.

Dr. Olaf Wiest has been cited for “contributions to interdisciplinary studies in computational chemistry, inorganic chemistry and drug design.” Dr. Wiest's interests extend to computational and physical organic chemistry, computational drug design, biophysical chemistry, enzyme mechanisms, transition metal catalyzed reactions and design of ligands for enantioselective catalysis. Among his accomplishments are discoveries that have advanced NPC research and the potential use of human histone deacetylases (HDACs) inhibitors in fighting cancer.



© University of Notre Dame

site author:clark.


Of Interest...